Page last updated: 2024-10-24

chloroquine and Laurence-Moon Syndrome

chloroquine has been researched along with Laurence-Moon Syndrome in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Laurence-Moon Syndrome: An autosomal recessive condition characterized by hypogonadism; spinocerebellar degeneration; MENTAL RETARDATION; RETINITIS PIGMENTOSA; and OBESITY. This syndrome was previously referred to as Laurence-Moon-Biedl syndrome until BARDET-BIEDL SYNDROME was identified as a distinct entity. (From N Engl J Med. 1989 Oct 12;321(15):1002-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KURACHI, Y1
YONEMURA, D1

Other Studies

1 other study available for chloroquine and Laurence-Moon Syndrome

ArticleYear
[ERG, WITH SPECIAL REFERENCE TO ITS CORRELATION WITH INTERNAL DISEASES].
    [Sogo rinsho] Clinic all-round, 1964, Volume: 13

    Topics: Anesthesia; Anesthesiology; Behcet Syndrome; Blood Circulation; Chloroquine; Diabetic Retinopathy; E

1964